TNBC, a subtype defined by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is widely recognized for its aggressive clinical behavior and high likelihood of recurrence, making it one of the most difficult forms of breast cancer to manage [2,3]. Here, ESR1 is linked to breast carcinoma.